| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.063 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |